Der Turmbau zu Babel

• References

• 1 AG Kardiovaskuläre Nuklearmedizin der Deutschen Gesellschaft für Nuklearmedizin. Hohe Strahlenbelastung durch die Myokardszinti - graphie: Status quo in Deutschland. 2011 Dtsch Med Wochenschr. (zur Publikation eingereicht).
• 2 Berrington de Gonzalez A, Kim KP, Smith-Bindman R, Mc Areavey D. Myocardial perfusion scans: Projected population cancer risks from current levels of use in the United States. Circulation 2010; 122: 2403-2410.
• 3 Bossenmayer S. Hohe Strahlenbelastungen durch Myokardszintigrahien?. Dtsch Med Wochenschr 2011; 136: 63.
• 4 Brenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277.
• 5 Bruckenberger E. Herzbericht 2009 mit Transplantationschirurgie. 2010 www.bruckenberger.de
• 6 Cerqueira MD. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010; 17: 709-718.
• 7 Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council, Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington DC: The National Academies Press; 2006
• 8 Einstein AJ, Weiner SD, Bernheim A. et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA 2010; 304: 2137-2144.
• 9 Eschner W, Schmidt M, Dietlein M, Schicha H. PROLARA: prognosis-based lifetime attributable risk approximation for cancer from diagnostic radiation exposure. Eur J Nucl Med Mol Imaging 2010; 37: 131-135.
• 10 Fazel R. et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009; 361: 849.
• 11 Freudenberg L, Muller S, Beyer T, Bockisch A. Subjective perception of radioactivity – no change post successful treatment with radioiodine. Nuklearmedizin 2009; 48: 84-88.
• 12 Glazer GM, Ruiz-Wibbelsmann JA. The invisible radiologist. Radiology 2011; 258: 18-22.
• 13 Gumprecht D. et al. Orientierungshilfe für radiologische und nuklearmedizinische Untersuchungen. Empfehlung der Strahlenschutzkommission. 1. Aufl. Berlin: Hoffmann; 2006
• 14 Hellwig D, Grigic A, Kotzerke J, Kirsch CM. Nuklearmedizin in Deutschland – Kennzahlen aus offiziellen Statistiken. Nuklearmedizin 2011; 50: 53-67.
• 15 Hendel RC, Berman DS, Di Carli MF. et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009. Appropriate use criteria for cardiac radionuclide imaging. J Am Coll Cardiol 2009; 53: 2201-2229.
• 16 Hricak H, Brenner DJ, Adelstein SJ. et al. Managing radiation use in medical imaging: A multifaceted challenge. Radiology 2011; 258: 889-905.
• 17 Lindner O, Burchert W, Bengel FM. et al. Myocardial perfusion scintigraphy 2008 in Germany – results of the fourth query. Nuklearmedizin 2010; 49: 65-72.
• 18 Sharples L, Hughes V, Crean A. et al. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technology Assessment 2007; 11 (49) iii-iv-ix-115.